Tejnaksh Health.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE030T01027
  • NSEID:
  • BSEID: 539428
INR
14.72
-0.47 (-3.09%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 3.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 999962,
    "name": "Tejnaksh Health.",
    "stock_name": "Tejnaksh Health.",
    "full_name": "Tejnaksh Healthcare Ltd",
    "name_url": "stocks-analysis/tejnaksh-health",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.72",
    "chg": -0.47,
    "chgp": "-3.09%",
    "dir": -1,
    "prev_price": "15.19",
    "mcapval": "30.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539428,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE030T01027",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "23:18 PM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "3.79 k",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tejnaksh-health-999962-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Tejnaksh Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-tejnaksh-healthcare-ltd-latest-results-good-or-bad-4032420",
        "imagepath": "",
        "date": "2026-06-02 19:32:07",
        "description": "Tejnaksh Healthcare Ltd's latest financial results for the quarter ending March 2026 illustrate a company facing significant operational challenges. The net sales for this quarter contracted by 20.56% year-on-year to ₹2.55 crores, marking the third consecutive quarter of year-on-year revenue decline. This trend raises concerns about the company's ability to attract and retain patients, particularly in a competitive healthcare market.\n\nDespite the decline in sales, the company reported a consolidated net profit of ₹0.36 crores, which reflects a sequential recovery of 20.00% from the previous quarter, although it represents a year-on-year decrease of 29.41%. This recovery in profitability is attributed to improved operating margins, which increased to 27.84% from 21.81% in the same quarter last year, indicating effective cost management and operational efficiency.\n\nThe operating profit margin improvement sugg..."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Upgraded to Sell on Improved Valuation Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-upgraded-to-sell-on-improved-valuation-metrics-4030278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_mojoScore_4030278.png",
        "date": "2026-06-02 09:07:29",
        "description": "Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 June 2026, driven primarily by a significant improvement in valuation metrics. Despite flat financial performance in the latest quarter and ongoing challenges in profitability, the stock’s more attractive valuation profile has prompted a reassessment of its investment appeal within the healthcare services sector."
      },
      {
        "title": "Tejnaksh Healthcare Q4 FY26: Margins Recover Amid Revenue Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/tejnaksh-healthcare-q4-fy26-margins-recover-amid-revenue-pressures-4028820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_quaterlyResult_4028820.png",
        "date": "2026-06-01 17:18:49",
        "description": "Tejnaksh Healthcare Ltd., the Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.36 crores for Q4 FY26 (January-March 2026), marking a sequential recovery of 20.00% over Q3 FY26 but declining 29.41% year-on-year. With a market capitalisation of ₹31.00 crores, the micro-cap healthcare services provider faces persistent revenue headwinds even as operating margins show signs of stabilisation."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-valuation-shifts-signal-changing-price-attractiveness-4025457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TejnakshHealthc_valuationdot_4025457.png",
        "date": "2026-06-01 08:06:08",
        "description": "Tejnaksh Healthcare Ltd, a micro-cap player in the healthcare services sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite this improvement in price metrics, the company’s stock performance remains mixed, with significant underperformance over longer time horizons compared to the Sensex. This article analyses the recent valuation changes, peer comparisons, and the implications for investors."
      },
      {
        "title": "Tejnaksh Healthcare Gains 6.38%: Valuation Shift Amidst Strong Sell Rating",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-gains-638-valuation-shift-amidst-strong-sell-rating-4022896",
        "imagepath": "",
        "date": "2026-05-30 13:05:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock surged 4.99% on strong intraday gains</p>\n                    <p><strong>26 May:</strong> Downgrade to Strong Sell announced alongside valuation shift</p>\n                    <p><strong>27 May:</strong> Continued price recovery with 1.79% gain</p>\n                    <p><strong>29 May:</strong> Slight pullback of 0.32% to close the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.14.42</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.15.34</div><div class=..."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Downgraded to Strong Sell Amidst Mixed Valuation and Weak Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-downgraded-to-strong-sell-amidst-mixed-valuation-and-weak-financial-trends-4012996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TejnakshHealthc_mojoScore_4012996.png",
        "date": "2026-05-26 08:48:49",
        "description": "Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Sell to Strong Sell as of 25 May 2026, driven primarily by a reassessment of its valuation metrics. Despite this upgrade, the company continues to face significant challenges in financial performance and market returns, underscoring a complex investment outlook for this micro-cap healthcare services provider."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-valuation-shifts-signal-changing-market-sentiment-4012475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TejnakshHealthc_valuationdot_4012475.png",
        "date": "2026-05-26 08:01:45",
        "description": "Tejnaksh Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions amid mixed financial metrics and sector comparisons. Despite a recent upgrade in valuation grade, the company’s stock performance and fundamental ratios suggest a complex investment landscape for healthcare services investors."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Falls 4.12%: Valuation Upgrade Amidst Weak Financials",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-falls-412-valuation-upgrade-amidst-weak-financials-4008298",
        "imagepath": "",
        "date": "2026-05-23 14:01:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Upgrade to Sell rating on improved valuation metrics</p>\n                    <p><strong>18 May:</strong> Valuation shifts signal renewed price attractiveness</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.14.42, down 4.12%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.15.04</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.14.42</div><div class=\"stat-change negative\">-4.12%</div></div>\n                    <div class=\"stat-item\"><div class=\"st..."
      },
      {
        "title": "When is the next results date for Tejnaksh Healthcare Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-tejnaksh-healthcare-ltd-4003884",
        "imagepath": "",
        "date": "2026-05-21 23:18:54",
        "description": "The next results date for Tejnaksh Healthcare Ltd is scheduled for 30 May 2026...."
      }
    ],
    "total": 178,
    "sid": "999962",
    "stock_news_url": "https://www.marketsmojo.com/news/tejnaksh-healthcare-999962"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.",
      "datetime": "30-May-2026",
      "details": "1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31 2026 and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations 2015 regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1 2026 and ending on March 31 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue in view of the postponement of the Companys expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026.",
      "datetime": "30-May-2026",
      "details": "Please find enclosed Audited financial results for March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015",
      "datetime": "20-May-2026",
      "details": "Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday May 30 2026 400060 to transact the business as given below: 1. To consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31 2026. 2. To transact any other matter with the permission of the Chair. Further in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation 2015 and in compliance of the circular no. LIST/COMP/ 01/2019-20 issued by BSE Limited on 02nd April 2019 intimation for the closure of trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 27th March 2026 till expiry of 48 hours after the declaration of audited financial results of the Company for the quarter and year ended 31st March 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>5:10</strong> stock split, ex-date: 19 Jul 23",
          "dt": "2023-07-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>36:10</strong> bonus issue, ex-date: 26 Apr 18",
          "dt": "2018-04-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Tejnaksh Healthcare Gains 6.38%: Valuation Shift Amidst Strong Sell Rating

2026-05-30 13:05:55

Key Events This Week

25 May: Stock surged 4.99% on strong intraday gains

26 May: Downgrade to Strong Sell announced alongside valuation shift

27 May: Continued price recovery with 1.79% gain

29 May: Slight pullback of 0.32% to close the week

stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.

30-May-2026 | Source : BSE

1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31 2026 and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations 2015 regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1 2026 and ending on March 31 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue in view of the postponement of the Companys expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.

Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026.

30-May-2026 | Source : BSE

Please find enclosed Audited financial results for March 2026

Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015

20-May-2026 | Source : BSE

Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday May 30 2026 400060 to transact the business as given below: 1. To consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31 2026. 2. To transact any other matter with the permission of the Chair. Further in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation 2015 and in compliance of the circular no. LIST/COMP/ 01/2019-20 issued by BSE Limited on 02nd April 2019 intimation for the closure of trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 27th March 2026 till expiry of 48 hours after the declaration of audited financial results of the Company for the quarter and year ended 31st March 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Tejnaksh Healthcare Ltd has announced 5:10 stock split, ex-date: 19 Jul 23

stock-summary
BONUS

Tejnaksh Healthcare Ltd has announced 36:10 bonus issue, ex-date: 26 Apr 18

stock-summary
RIGHTS

No Rights history available